Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Crivellari

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Dose-finding and pharmacologic study of chronic oral idarubicin therapy in metastatic breast cancer patientsG Toffoli, R Sorio, P Aita, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
Combination chemotherapy with navelbine and continuous infusion of 5-fluorouracil in metastatic, chemotherapy refractory breast cancerD Lombardi, M D Magri, D Crivellari, et al.
Tumori|August 31, 1979
Clinical and immunological evaluation of 5 cases of mycosis fungoides in advanced stagesU Tirelli, A Veronesi, E Galligioni, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1987
Sequential combination of tamoxifen and high dose medroxyprogesterone acetate: therapeutic and endocrine effects in postmenopausal advanced breast cancer patientsG Gasparini, L Canobbio, E Galligioni, et al.
Cancer|July 1, 1987
Intermittent pelvic arterial infusion with peptichemio, doxorubicin, and cisplatin for locally advanced and recurrent carcinoma of the uterine cervixC Scarabelli, S Tumolo, A De Paoli, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Cisplatin and etoposide versus cyclophosphamide, epirubicin and vincristine in small cell lung cancer: a randomised studyA Veronesi, G Cartei, D Crivellari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2006
Innovative schedule of oral idarubicin in elderly patients with metastatic breast cancer: comprehensive results of a phase II multi-institutional study with pharmacokinetic drug monitoringD Crivellari, D Lombardi, G Corona, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|April 1, 1993
[Evaluation of the specific delayed cutaneous hypersensitivity response(DTCH) after specific active immunotherapy (SAI) using autologous tumor cells in patients operated upon for renal carcinoma]M Francini, E Galligioni, A Carbone, et al.
Cancer Treatment Reports|May 1, 1982
Combined chemotherapy with doxorubicin, bleomycin, vinblastine, decarbazine, and radiotherapy for advanced lymphoepitheliomaE Galligioni, A Carbone, U Tirelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 5, 2005
Dose-finding study of weekly docetaxel, anthracyclines plus fluoropyrimidines as first-line treatment in advanced breast cancerO Pagani, C Sessa, F Nolè, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Dose-finding and pharmacologic study of chronic oral idarubicin therapy in metastatic breast cancer patientsG Toffoli, R Sorio, P Aita, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
Combination chemotherapy with navelbine and continuous infusion of 5-fluorouracil in metastatic, chemotherapy refractory breast cancerD Lombardi, M D Magri, D Crivellari, et al.
Tumori|August 31, 1979
Clinical and immunological evaluation of 5 cases of mycosis fungoides in advanced stagesU Tirelli, A Veronesi, E Galligioni, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1987
Sequential combination of tamoxifen and high dose medroxyprogesterone acetate: therapeutic and endocrine effects in postmenopausal advanced breast cancer patientsG Gasparini, L Canobbio, E Galligioni, et al.
Cancer|July 1, 1987
Intermittent pelvic arterial infusion with peptichemio, doxorubicin, and cisplatin for locally advanced and recurrent carcinoma of the uterine cervixC Scarabelli, S Tumolo, A De Paoli, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Cisplatin and etoposide versus cyclophosphamide, epirubicin and vincristine in small cell lung cancer: a randomised studyA Veronesi, G Cartei, D Crivellari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2006
Innovative schedule of oral idarubicin in elderly patients with metastatic breast cancer: comprehensive results of a phase II multi-institutional study with pharmacokinetic drug monitoringD Crivellari, D Lombardi, G Corona, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|April 1, 1993
[Evaluation of the specific delayed cutaneous hypersensitivity response(DTCH) after specific active immunotherapy (SAI) using autologous tumor cells in patients operated upon for renal carcinoma]M Francini, E Galligioni, A Carbone, et al.
Cancer Treatment Reports|May 1, 1982
Combined chemotherapy with doxorubicin, bleomycin, vinblastine, decarbazine, and radiotherapy for advanced lymphoepitheliomaE Galligioni, A Carbone, U Tirelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 5, 2005
Dose-finding study of weekly docetaxel, anthracyclines plus fluoropyrimidines as first-line treatment in advanced breast cancerO Pagani, C Sessa, F Nolè, et al.
Pageof 9